Diffuse Large B-Cell Lymphoma News

News

Antibody-Drug Conjugate Addresses Unmet Need in R/R DLBCL

04/08/2022

Three clinical trials showed a CD19-targeted antibody-drug conjugate demonstrated safety and tolerability while encouraging antitumor activity in patients with relapsed/refractory diffuse large B-cell lymphoma.

Three clinical trials showed a...

04/08/2022

First Report Managed Care

News

Outpatient High-dose Methotrexate Administered Safely in Select Patients With DLBCL

09/30/2021

Maria Asimopoulos ;

Authors of a recent study evaluated new protocols for the administration of outpatient high-dose methotrexate for patients with diffuse large B-cell lymphoma, which is typically administered in an inpatient setting due to its complex...

Authors of a recent study...

09/30/2021

First Report Managed Care

News

Cost Burden Linked With CAR-T Therapy for R/R DLBCL

09/24/2021

Jolynn Tumolo ;

A recent study summarized data from four real-world trials that reported rates of adverse events and health care resource use associated with the two chimeric antigen receptor T-cell (CAR-T) therapies.

A recent study summarized data...

09/24/2021

First Report Managed Care

News

Examining the Cost-Effectiveness of a Treatment for Patients With DLBCL

08/30/2021

Julie Gould ;

A recent study found that tisagenlecleucel is a cost-effective treatment option for relapsed or refractory diffuse large B-cell lymphoma, with an estimated savings ranging from over $600,000 and up to $1.5 million.

A recent study found that...

08/30/2021

First Report Managed Care

News

Health Care Resource Utilization Among Patients With DLBCL

08/23/2021

Jolynn Tumolo ;

According to data findings, patients with diffuse large b-cell lymphoma treated with CAR-T therapy in the outpatient setting had a lower number of inpatient and ICU visits compared with patients receiving CAR-T therapy in the inpatient...

According to data findings,...

08/23/2021

First Report Managed Care

News

Uninsured Patients With DLBCL Have Inferior Overall Survival

07/27/2021

Jolynn Tumolo ;

“Despite the lack of major changes in DLBCL therapies,” the authors wrote, “a diagnosis after the implementation of the Affordable Care Act (in 2010 or later) was associated with a superior overall survival when compared with the outcomes of...

“Despite the lack of major...

07/27/2021

First Report Managed Care

News

Patients With DLBCL Made Up Majority of CAR T-Cell Therapy Hospitalizations in 2018

07/19/2021

Jolynn Tumolo ;

A recent study looked at real-world outcomes of patients hospitalized to receive CAR T-cell therapy for DLBCL, primary mediastinal large B-cell lymphoma, and B-cell precursor acute lymphoblastic leukemia.

A recent study looked at...

07/19/2021

First Report Managed Care

News

Prophylactic High-Dose Methotrexate Does Not Improve Outcomes in High-Risk DLBCL

06/14/2021

Jolynn Tumolo ;

The use of prophylactic high-dose methotrexate in patients with diffuse large B-cell lymphoma at high risk for central nervous system (CNS) relapse did not have improved CNS relapse rates or survival, according to a real-world study.

The use of prophylactic...

06/14/2021

First Report Managed Care

News

Examining Benefits of Various Treatment Options for DLBCL Patients

06/07/2021

Jolynn Tumolo ;

“Overall, these results provide consistent evidence supporting the effectiveness of [lisocabtagene maraleucel] for the treatment of patients with R/R DLBCL,” researchers concluded.

“Overall, these results provide...

06/07/2021

First Report Managed Care

News

Therapy Produces Durable Responses in Patients With R/R DLBCL

06/01/2021

Jolynn Tumolo ;

“Loncastuximab tesirine has substantial single-agent antitumor activity and produces durable responses with an acceptable safety profile,” researchers concluded, “potentially offering a new therapeutic option for heavily pretreated patients...

“Loncastuximab tesirine has...

06/01/2021

First Report Managed Care

Current Issue

September 2024

Volume 21

Issue 3

Current Issue

Issue Archive

What's Trending?

Conference Insider

New Links in the Risk for Alzheimer’s Disease

01/20/2015

Eileen Koutnik-Fotopoulos ;

The search for an effective treatment for Alzheimer’s disease (AD) has been elusive. While beta-amyloid and phosphorylated tau protein have been research targets, the positive results of early trials have not been validated.

The search for an effective...

01/20/2015

First Report Managed Care

News

Rep. Ellmers wants health IT push to focus on errors

08/15/2011

First Report Managed Care

News

Diabetes Training Programs are Underused

12/02/2014

Newly diagnosed diabetics generally don't take advantage of educational programs that could help them manage their disease.

Newly diagnosed diabetics...

12/02/2014

First Report Managed Care

News

Mental Health Management Housing Program Cuts Hospital Costs

12/15/2017

A program that granted homeless patients housing has reduced hospital health care spending and improved mental health outcomes.

A program that granted homeless...

12/15/2017

First Report Managed Care

Risks of In-Hospital Worsening Heart Failure

12/15/2014

Mary Mihalovic ;

The results of a recent study found that in-hospital worsening heart failure was common and associated with higher rates of mortality, all-cause readmission, and Medicare payments.

The results of a recent study...

12/15/2014

First Report Managed Care

Video Insights

Videos

Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care

11/13/2024

David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...

David Sand, MD, MBA, chief...

11/13/2024

First Report Managed Care

Videos

The Evolving Role of CGRP-targeting Therapies in Migraine Prevention

10/31/2024

Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.

Richard Lipton, MD, provides...

10/31/2024

First Report Managed Care

Videos

Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer

09/26/2024

Alexander Spira , MD, PhD;

Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).

Alexander I. Spira, MD, PhD,...

09/26/2024

First Report Managed Care

Videos

Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives

09/25/2024

Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.

Learn about research...

09/25/2024

First Report Managed Care

Videos

Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable

09/04/2024

View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.

View a roundtable discussion on...

09/04/2024

First Report Managed Care

Videos

Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions

08/15/2024

Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...

Guest expert Jordan Bazinsky...

08/15/2024

First Report Managed Care

Videos

Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia

08/14/2024

Farrukh T. Awan , MD;

Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).

Farrukh Awan, MD, highlights...

08/14/2024

Journal of Clinical Pathways

Videos

Evolving Health Care Contact Centers Into Drivers of Value-Based Care

07/31/2024

Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.

Discover how health care contact...

07/31/2024

First Report Managed Care

Videos

Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024

06/11/2024

Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations

Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...

Key stakeholders in the health...

06/11/2024

First Report Managed Care

Melissa Andel, Principal, CommonHealth Solutions, LLC

Videos

Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers

05/24/2024

Melissa Andel, Principal, CommonHealth Solutions, LLC

Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.

Diffuse Large B-Cell Lymphoma News

Current Issue

What's Trending?

Video Insights

Subscribe to our eNewsletters!

Specialties

Events

Year Round Education

HMP Global Products